Scarica l'app Stockscreener
3.83
2.54%
-0.10
Precedente Chiudi:
$3.93
Aprire:
$3.93
Volume 24 ore:
56,244
Relative Volume:
0.31
Capitalizzazione di mercato:
$41.36M
Reddito:
-
Utile/perdita netta:
$-19.25M
Rapporto P/E:
-2.1517
EPS:
-1.78
Flusso di cassa netto:
$-17.87M
1 W Prestazione:
-11.14%
1M Prestazione:
-13.93%
6M Prestazione:
-0.26%
1 anno Prestazione:
+1.06%
Intervallo 1D:
$3.81
$3.9473
Intervallo di 1 settimana:
$3.7411
$4.45
Portata 52W:
$2.55
$6.118
Lantern Pharma Inc Stock (LTRN) Company Profile
Nome
Lantern Pharma Inc
Settore
Industria
Telefono
972-277-1136
Indirizzo
1920 MCKINNEY AVENUE, DALLAS, TX
Confronta LTRN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LTRN
Lantern Pharma Inc
|
3.83 | 42.77M | 0 | -19.25M | -17.87M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-07 | Iniziato | H.C. Wainwright | Buy |
Lantern Pharma Inc Borsa (LTRN) Ultime notizie
Lantern Pharma (NASDAQ: LTRN) CEO Panna Sharma Featured on IBN’s BioMedWire Podcast - Barchart.com
IBN Announces Latest Episode of The BioMedWire Podcast - GlobeNewswire
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Panna Sharma, CEO of AI-Driven Biotech Focused on Challenging & Rare Cancers, Lantern Pharma Inc. (LTRN) - GlobeNewswire Inc.
Lantern Pharma Inc. At Decision Level — Rebound or Resistance2025 Buyback Activity & Comprehensive Market Scan Reports - beatles.ru
Does Lantern Pharma Inc. align with a passive investing strategyJuly 2025 Selloffs & Technical Pattern Recognition Alerts - beatles.ru
Sentiment analysis tools applied to Lantern Pharma Inc.July 2025 Gainers & Weekly Breakout Opportunity Watchlist - Newser
How liquid is Lantern Pharma Inc. stockJuly 2025 Volume & Weekly Return Optimization Plans - خودرو بانک
Can Lantern Pharma Inc. disrupt its industryQuarterly Portfolio Summary & High Accuracy Swing Trade Signals - خودرو بانک
Can Lantern Pharma Inc. grow without dilution2025 Retail Activity & Stock Portfolio Risk Management - 더경남뉴스
Is Lantern Pharma Inc. stock trending bullishPortfolio Performance Summary & Verified Momentum Stock Watchlist - خودرو بانک
Lantern Pharma Inc. stock volume spike explainedTrade Risk Assessment & AI Powered Market Entry Ideas - Newser
Lantern Pharma Inc. stock chart pattern explained2025 Fundamental Recap & High Accuracy Investment Signals - Newser
Can Lantern Pharma Inc. lead its sector in growthQuarterly Trade Summary & AI Enhanced Execution Alerts - خودرو بانک
Hoth Therapeutics shares fall 2.24% premarket after adopting Lantern Pharma's AI-driven drug development tool. - AInvest
How sentiment analysis helps forecast Lantern Pharma Inc.Portfolio Return Report & Growth-Oriented Investment Plans - Newser
Using data tools to time your Lantern Pharma Inc. exitJuly 2025 Reactions & High Accuracy Investment Signals - Newser
Hoth Therapeutics shares fall 1.49% after-hours after adopting Lantern Pharma's AI-driven drug development tool. - AInvest
Lantern Pharma (NASDAQ: LTRN) Completes FDA Type C Meeting, Gains Guidance for Planned Pediatric CNS Cancer Trial - The Globe and Mail
Lantern Pharma shares fall 1.52% intraday after FDA meeting and Hoth Therapeutics partnership. - AInvest
AI-Driven Drug Development: Hoth Therapeutics and Lantern Pharma’s Strategic Partnership to Revolutionize CNS Therapies - AInvest
Lantern Pharma's PredictBBB.ai Platform to Drive Next-Gen Drug Development with Hoth Therapeutics Partnership - AInvest
Hoth Therapeutics Taps Lantern Pharma's PredictBBB.ai Platform -- Breakthrough AI With 94% Accuracy Driving Next-Gen Drug Development - WV News
Detecting support and resistance levels for Lantern Pharma Inc.CEO Change & Smart Swing Trading Alerts - Newser
What data driven models say about Lantern Pharma Inc.’s future2025 Breakouts & Breakdowns & Safe Entry Zone Identification - Newser
Will breakout in Lantern Pharma Inc. lead to full recoveryBear Alert & Fast Moving Stock Trade Plans - Newser
Lantern Pharma Receives FDA Guidance for Pediatric CNS Cancer Trial of AI-Discovered Therapy - citybuzz -
Automated trading signals detected on Lantern Pharma Inc.Market Movement Recap & Detailed Earnings Play Alerts - Newser
Lantern Pharma announces completion of Type C meeting with FDA - MSN
Lantern Pharma receives FDA feedback on pediatric brain cancer trial - Investing.com
Lantern Pharma Completes FDA Type C Meeting, Advances Pediatric CNS Cancer Trial with FDA Guidance - AInvest
Lantern Pharma Announces Completion of Type C Meeting with FDA, Providing Clarity on Regulatory Pathway for Pediatric CNS Cancer Trial - Business Wire
Top chart patterns to watch in Lantern Pharma Inc.July 2025 Review & Daily Chart Pattern Signals - Newser
What is Lantern Pharma Inc.’s book value per shareWeekly Profit Report & Risk Controlled Daily Trade Plans - خودرو بانک
How high can Lantern Pharma Inc. stock goMarket Sentiment Summary & Daily Profit Focused Stock Screening - Newser
Market reaction to Lantern Pharma Inc.’s recent newsWeekly Stock Analysis & Risk Managed Investment Strategies - Newser
How to integrate Lantern Pharma Inc. into portfolio analysis toolsJuly 2025 Weekly Recap & Fast Gain Stock Trading Tips - Newser
Will Lantern Pharma Inc. price bounce be sustainableWeekly Trade Analysis & Low Risk High Reward Trade Ideas - Newser
What machine learning models say about Lantern Pharma Inc.Fed Meeting & Accurate Entry/Exit Alerts - Newser
Does Lantern Pharma Inc. show high probability of reboundJuly 2025 Levels & Weekly High Return Opportunities - Newser
Is Lantern Pharma Inc. a cyclical or defensive stock2025 Market Trends & Weekly Market Pulse Alerts - خودرو بانک
Custom strategy builders for tracking Lantern Pharma Inc.Weekly Trend Summary & Target Return Focused Picks - Newser
Is Lantern Pharma Inc. vulnerable to short sellersBond Market & Low Volatility Stock Recommendations - خودرو بانک
Aug Rallies: What is the next catalyst for Lantern Pharma Inc.Market Volume Report & Safe Entry Trade Reports - خودرو بانک
Using Bollinger Bands to evaluate Lantern Pharma Inc.M&A Rumor & Stock Portfolio Risk Control - Newser
Can Lantern Pharma Inc. reach resistance levels soon2025 Market Trends & Fast Gaining Stock Strategy Reports - خودرو بانک
Lantern Pharma Inc Azioni (LTRN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lantern Pharma Inc Azioni (LTRN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kreis Leslie W. | 10% Owner |
Jun 13 '25 |
Sale |
3.09 |
40,000 |
123,600 |
49,957 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 12 '25 |
Sale |
3.38 |
60,647 |
204,987 |
51,860 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 11 '25 |
Sale |
3.40 |
950 |
3,230 |
54,746 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 10 '25 |
Sale |
3.40 |
16 |
54 |
54,791 |
| Kreis Leslie W. | 10% Owner |
Jun 12 '25 |
Sale |
3.38 |
60,647 |
204,987 |
51,860 |
| Kreis Leslie W. | 10% Owner |
Jun 11 '25 |
Sale |
3.40 |
950 |
3,230 |
54,746 |
| Kreis Leslie W. | 10% Owner |
Jun 10 '25 |
Sale |
3.40 |
16 |
54 |
54,791 |
| Fletcher Aaron G.L. | 10% Owner |
May 27 '25 |
Sale |
3.05 |
21,037 |
64,163 |
56,467 |
| Fletcher Aaron G.L. | 10% Owner |
May 29 '25 |
Sale |
3.03 |
20,200 |
61,206 |
54,792 |
| Fletcher Aaron G.L. | 10% Owner |
May 28 '25 |
Sale |
2.87 |
15,000 |
43,050 |
55,753 |
0.93%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):